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Clinical Relevancy Statement {#jpen1606-sec-0050}
============================

Malnourished patients are at increased risk of complications during hospitalization and are at further risk for adverse health events after discharge. Home health agencies are ideal partners to identify and treat patients with poor nutrition status and help healthcare organizations achieve better patient satisfaction, improved quality of care, and decreased costs. The clinical implications of our findings are that (1) malnutrition risk screening and at‐home use of oral nutritional supplements as part of nutrition‐focused care can reduce 30‐day, 60‐day, and 90‐day hospitalization rates and healthcare resource utilization, thus yielding significant cost savings, and (2) nutrition care is important throughout the continuum of care.

Introduction {#jpen1606-sec-0060}
============

As many as half of patients entering the hospital are malnourished,[1](#jpen1606-bib-0001){ref-type="ref"}, [2](#jpen1606-bib-0002){ref-type="ref"} particularly older adults.[3](#jpen1606-bib-0003){ref-type="ref"} Even among patients whose nutrition status is adequate upon admission, many experience nutrition deterioration during their hospital stay.[4](#jpen1606-bib-0004){ref-type="ref"} Malnourished patients are at increased risk of complications during hospitalization and are at further risk for adverse health events after discharge.[5](#jpen1606-bib-0005){ref-type="ref"} Thus, malnutrition remains a significant concern among adults receiving healthcare services in postacute care settings.[6](#jpen1606-bib-0006){ref-type="ref"}, [7](#jpen1606-bib-0007){ref-type="ref"}, [8](#jpen1606-bib-0008){ref-type="ref"} Yet, malnutrition often goes unrecognized during the hospital stay and continues to be overlooked after discharge.[9](#jpen1606-bib-0009){ref-type="ref"} For example, results of a U.S. study showed that about 25% of adults receiving home health services were at moderate‐to‐high nutrition risk.[10](#jpen1606-bib-0010){ref-type="ref"} Therefore, home health agencies (HHAs) are ideal partners to identify and treat patients with poor nutrition status and help healthcare organizations achieve better patient satisfaction, improved quality of care, and decreased costs.[11](#jpen1606-bib-0011){ref-type="ref"}

In fact, postacute care is one of the fastest‐growing areas of healthcare spending in the United States,[12](#jpen1606-bib-0012){ref-type="ref"}, [13](#jpen1606-bib-0013){ref-type="ref"} accounting for the largest increase in Medicare spending.[14](#jpen1606-bib-0014){ref-type="ref"} A goal of all postacute providers, and HHAs in particular, is to prevent hospital readmissions within 30 days of discharge or in the first 30 days of home health enrollment.[15](#jpen1606-bib-0015){ref-type="ref"} Notably, costs of unplanned hospital readmissions are up to \$12 billion each year among Medicare beneficiaries,[16](#jpen1606-bib-0016){ref-type="ref"} and patient readmissions are increasingly used as quality‐of‐care measures for provider reimbursements.[17](#jpen1606-bib-0017){ref-type="ref"}

Advocate Health Care (AHC) previously conducted a nutrition‐focused quality improvement program (QIP) at 4 hospitals; this QIP significantly reduced hospital length of stay and 30‐day readmissions in at‐risk and malnourished patients.[18](#jpen1606-bib-0018){ref-type="ref"} Such benefits were associated with lower healthcare costs.[19](#jpen1606-bib-0019){ref-type="ref"} Our current AHC study evaluated the impact of a nutrition‐focused QIP on 90‐day hospitalization rates and healthcare resource utilization by at‐risk or malnourished adults under HHA care. The QIP focused on bolstering patient‐centered nutrition care using mandatory nutrition screening upon admission to home health, patient and caregiver education, motivational interviewing on nutrition, and provision of oral nutritional supplements (ONSs) when appropriate.

Methods {#jpen1606-sec-0070}
=======

Study Design {#jpen1606-sec-0080}
------------

AHC, a not‐for‐profit provider, is the largest integrated healthcare delivery system in Illinois. AHC serves individuals, families, and communities across metropolitan Chicago and central Illinois. AHC provides inpatient and outpatient services, home health services, hospice, counseling, physician services, and healthcare education programs and is recognized for clinical excellence in trauma, cardiovascular services, cancer care, and neurology. This study was a multisite, pre‐post QIP implemented at 2 HHA branches of AHC. Patients were enrolled to the QIP between December 27, 2016, and December 7, 2017. The primary outcome was risk of hospitalization within 90 days of HHA enrollment. The study was approved by the AHC Institutional Review Board. This trial was registered under ClinicalTrials.gov identifier no. NCT03011944.

Patients and Controls {#jpen1606-sec-0090}
---------------------

Patients were eligible for the QIP if they were admitted to the HHA from an AHC hospital, outpatient clinic, or affiliated skilled nursing facility (SNF); ≥18 years of age; at risk for malnutrition upon hospital discharge (score of ≥2 on the Malnutrition Screening Tool) and/or on admission to the HHA (score of ≥30 on the Nutritional Health Screen, \[NHS\], Appendix Figure [A1](#jpen1606-fig-0001){ref-type="fig"}); and able to consume food and beverages orally. Patients were excluded if they were pregnant, were intubated or receiving tube feeding or parenteral nutrition, had severe dementia or delirium, had a history of significant psychiatric disorder, were receiving hospice care, had any other disorder or condition that would interfere with ONS consumption, declined to participate, or did not have an existing relationship with an AHC hospital, outpatient clinic, or affiliated SNF.

Two control groups were established---historic and concurrent. The historic group included at‐risk and malnourished patients enrolled at the same 2 branches of the HHA during the 12 months prior to the QIP start (December 27, 2015--December 26, 2016). As the NHS tool was not always used prior to the QIP, proxy measures also identified at‐risk and malnourished patients: (1) malnutrition‐related diagnoses (*International Classification of Diseases, Ninth Revision* \[*ICD‐9*\] codes 263.0--263.9), (2) ONS orders during hospital admission, or (3) malnutrition‐related documentation in physician notes on outpatient medical records. The concurrent control group included at‐risk and malnourished patients enrolled at all branches of the HHA (n = 5) during the same 12 months of the implementation of the QIP (December 27, 2016--December 7, 2017). This group was identified using NHS tool results or proxy measures, as described above.

The QIP and control groups had 3 patient subgroups. Group 1 consisted of at‐risk and malnourished hospital patients discharged to the HHA; group 2 consisted of at‐risk and malnourished outpatients admitted to the HHA; and group 3 consisted of at‐risk and malnourished patients discharged from SNF to HHA.

Program and Study Site {#jpen1606-sec-0100}
----------------------

AHC\'s HHA is Joint Commission accredited and serves the Chicago and central Illinois areas. The HHA team provides skilled nursing and other therapeutic services to help patients manage their health conditions independently. The program focuses on individualized treatment, including overall coordination of care with patients' healthcare providers. HHA has 5 branches, caring for 13,000 patients/year; the 2 largest branches participated in this QIP.

Measures {#jpen1606-sec-0110}
--------

The primary endpoint was the rate of unplanned hospitalizations (including hospital readmission and admission) within 90 days of HHA enrollment. The secondary endpoint was healthcare resource utilization during the 90‐day follow‐up period. Healthcare resource utilization included hospitalizations, emergency department (ED) visits, and outpatient visits within the AHC network. Outpatient visits included ambulatory visits, imaging visits, and laboratory visits.

The following baseline sociodemographic variables were collected: patient characteristics (age, sex, race), referral status (patients admitted from hospitals, outpatient clinic, or SNF), health insurance type (private, public, self‐pay, other, or unknown), ONS type during HHA stay, patient clinical characteristics (surgery vs medical status), and most common diagnostic profiles (myocardial infarction \[MI\], congestive heart failure \[CHF\], chronic obstructive pulmonary disease \[COPD\], diabetes, and malignancy).

Nutrition Intervention {#jpen1606-sec-0120}
----------------------

Patients were screened for malnutrition risk with NHS, a tool used by Medicare‐certified HHAs and built into the HHA\'s Allscripts electronic medical record (EMR) system. During the initial HHA visit, screening was completed by the admitting clinician (a nurse or physical therapist), who underwent training on NHS completion requirements. Clinicians were initially trained during an in‐person, scenario‐based group session. Additional training before and during the QIP implementation was provided on an individual basis by the clinical manager. The AHC lead registered dietitian was involved in developing the training materials and also conducting sessions as needed. The NHS tool uses 15 questions on nutrition status; a score is calculated based on patient responses (Appendix Figure [A1](#jpen1606-fig-0001){ref-type="fig"}). Patients were designated as good nutrition status (0--25 points), moderate nutrition risk (30--55 points), or high nutrition risk (60--100 points). Patients with moderate or high risk were flagged for intervention. A customized nutrition care plan, including ONS use during HHA care, was generated in the EMR. The admitting clinician ordered standard (Ensure, 2 bottles/d), diabetes‐specific (Glucerna, 2 bottles/d), or renal‐specific (Nepro, 1 bottle/d) according to the patient\'s dietary needs; ONS was provided to each enrolled patient for up to 30 days. A standard QIP ONS protocol was developed by the AHC lead dietitian, as dietitians were not available in HHAs to meet with patients to customize their dietary plan. The recommended ONS type and associated amounts were informed by standard nutrition protocols and guidelines. ONS was delivered directly to the patient\'s home within approximately 48--72 hours of enrollment in HHA. Clinicians used an allergy‐based algorithm to inform product selection; patients made flavor choices.

The plan was reviewed at each patient visit, and nutrition status was documented in the patient\'s chart. Patients were educated on the importance of nutrition and the benefits of ONS using the teach‐back method. In subsequent HHA visits, patients were reminded of the importance of nutrition, and caring clinicians used motivational interviewing strategies to encourage adherence to the ONS regimen. Coupons for discounts on ONS purchases were distributed to all participating QIP patients to replicate current practice.

Within 30--45 days after admission to the HHA, QIP patients were contacted by telephone and asked to participate in a survey. The survey included questions on patient experience, consumption of ONS, likelihood of ONS use post--HHA discharge, and clinician nutrition practices.

Data Sources and Management {#jpen1606-sec-0130}
---------------------------

For most QIP analyses, archival data were obtained from the AHC‐wide Electronic Data Warehouse database. Additional data were abstracted from EMRs of hospitals and HHA, and patient survey data were compiled and summarized.

Fixed and variable QIP program costs were estimated using specific HHA staff time recorded for the QIP processes and the associated hourly wage rates from the 2017 Bureau of Labor Statistics.[20](#jpen1606-bib-0020){ref-type="ref"} The costs included those associated with patient screening and assessment (\$67,043, n = 5688), patient and caregiver education, follow‐up calls, survey administration, and other QIP procedures (\$164,470, n = 1546). Costs for ONS and delivery (\$171,281, n = 1546) were also included. The cost of hospitalization for malnourished adult patients of \$17,985 was from the 2016 Healthcare Cost and Utilization Project (HCUP) report.[21](#jpen1606-bib-0021){ref-type="ref"} Average costs of ED and outpatient visits of \$1252 and \$511, respectively, were from the Medical Expenditure Panel Survey (2013).[22](#jpen1606-bib-0022){ref-type="ref"}

Statistical Analysis {#jpen1606-sec-0140}
--------------------

Descriptive statistics were calculated. Between‐group analyses were performed by comparing QIP patients with controls (either historic or concurrent) using the χ^2^ test for categorical variables and the *t*‐test for continuous variables. A Poisson regression model was used to estimate the risk of hospitalization during the 30‐day, 60‐day, or 90‐day period while accounting for age, sex, race, insurance, referral source, MI, CHF, COPD, diabetes, and malignancy. Descriptive statistics were calculated for healthcare resource utilization outcomes. A generalized linear regression model with Poisson distribution and log link was used to estimate risk reduction in resource utilization between the 2 cohorts. Analyses were performed with SPSS 22.0 and SAS 9.3; a 2‐tailed *P*‐value ≤ 0.05 was considered statistically significant.

Propensity Score Matching and Sensitivity Analysis {#jpen1606-sec-0150}
--------------------------------------------------

Propensity score matching (PSM) matched historic and concurrent controls to QIP patients. To estimate the propensity scores, a logistic regression model was used, adjusting for age, sex, race, insurance status, prevalent diagnoses (MI, CHF, COPD, diabetes, and malignancy), HHA admission branch (south vs north), and referral source (hospital, outpatient clinic, or SNF). The greedy algorithm was used for between‐group matching.[23](#jpen1606-bib-0023){ref-type="ref"}

A sensitivity analysis compared hospitalization and healthcare resource utilization results across the different comparative analyses: QIP vs historic controls, QIP vs concurrent controls, PSM QIP vs historic controls, and PSM QIP vs concurrent controls.

Cost Analysis {#jpen1606-sec-0160}
-------------

Costs incurred from hospitalizations, ED and outpatient visits, and QIP implementation were analyzed in a descriptive manner for QIP and historic control groups. Sensitivity analysis compared cost findings of this analysis with those from the remaining 3 comparative analyses: QIP vs concurrent controls, PSM QIP vs historic controls, and PSM QIP vs concurrent controls.

Sample Size Calculation {#jpen1606-sec-0170}
-----------------------

Initial sample size calculation assumed a 20% relative‐risk (RR) reduction for 90‐day hospitalization between QIP patients and historic controls. With 95% confidence interval (CI), power of 80%, and a 2‐sided α of 5%, we estimated a total enrollment of 1800 patients. A preplanned interim power analysis was performed upon enrollment of 30% of QIP patients. Hospitalization rates were 25% for historic controls vs 19.2% for QIP patients, and the required sample size was reestimated as 1450 QIP patients. To account for potential patient attrition, the decision was made to run the QIP longer, which led to enrollment of 1546 QIP patients.

Results {#jpen1606-sec-0180}
=======

Patient Demographics {#jpen1606-sec-0190}
--------------------

Of 5688 patients screened, 2206 (38.8%) patients were identified as at risk of malnutrition. Of these, 2135 patients (37.5%) were found to be at moderate nutrition risk, whereas 71 patients (1.3%) were at high risk; 1546 (70%) met the QIP eligibility criteria. Data were collected for 1546 QIP patients, 7413 historic control patients, and 5235 concurrent control patients. Since the results of the sensitivity analysis were consistent among all 4 comparative analyses (QIP vs historic controls, QIP vs concurrent controls, PSM QIP vs historic controls, and PSM QIP vs concurrent controls), we report the results of all 4 comparative analyses only for the primary outcome of interest, hospitalization. Results on demographic characteristics and healthcare resource utilization are reported only for QIP patients vs historic controls, as other results were similar.

Table [1](#jpen1606-tbl-0001){ref-type="table"} shows demographic information for QIP and historic control groups. Overall, QIP patients were older (mean age = 76.8 years), with 83.5% of patients ≥65 years of age compared with 75.3% in the historic control group. Most QIP participants were admitted from hospitals (n = 1049; 67.9%), whereas 19.0% (n = 294) and 13.1% (n = 203) came from SNFs and outpatient clinics, respectively. In the historic control group, 62.8% (n = 4653) were admitted from hospitals, whereas 27.5% (n = 2038) and 9.7% (n = 722) came from SNFs and outpatient clinics, respectively. Comparing the race of QIP and historic control patients, significantly more QIP participants were nonwhite (black or other). There were no significant differences between groups regarding sex and diagnoses (MI, CHF, COPD, diabetes, or malignancy) distribution; fewer of the QIP group were surgical patients, as compared with the control group.

###### 

Demographic Characteristics of Participants in the QIP and Historic Control Groups

  Characteristic                                           QIP (n = 1546)   Historic Control (n = 7413)   *P*‐value
  -------------------------------------------------------- ---------------- ----------------------------- -----------
  Age, years[a](#jpen1606-tbl1-note-0003){ref-type="fn"}   76.8 (12.8)      73.7 (13.5)                   \<0.0001
  Age group, %                                                                                            \<0.0001
  \<65                                                     255 (16.5)       1828 (24.7)                   
  ≥65                                                      1291 (83.5)      5585 (75.3)                   
  Gender, %                                                                                               0.90
  Female                                                   921 (59.6)       4404 (59.4)                   
  Male                                                     625 (40.4)       3009 (40.6)                   
  Race, %                                                                                                 \<0.0001
  White                                                    734 (47.5)       4264 (57.5)                   
  Black                                                    587 (38.0)       2579 (34.8)                   
  Other                                                    225 (14.6)       570 (7.7)                     
  Referral source, %                                                                                      \<0.0001
  Hospital                                                 1049 (67.9)      4653 (62.8)                   
  Outpatient clinic                                        203 (13.1)       722 (9.7)                     
  Skilled nursing facility                                 294 (19.0)       2038 (27.5)                   
  Insurance, %                                                                                            \<0.0001
  Private                                                  270 (17.5)       1318 (17.8)                   
  Public                                                   1248 (80.7)      6028 (81.3)                   
  Self‐pay                                                 7 (0.5)          26 (0.4)                      
  Other                                                    8 (0.5)          41 (0.6)                      
  Unknown                                                  13 (0.8)         0 (0.0)                       
  ONS type during home health, %                                                                          NA
  Standard (Ensure)                                        935 (60.5)                                     
  Diabetes‐specific (Glucerna)                             539 (34.3)                                     
  Renal‐specific (Nepro)                                   81 (5.2)                                       
  Surgical patients, %                                                                                    \<0.0001
  Yes                                                      489 (31.6)       2845 (38.4)                   
  No                                                       1057 (68.4)      4568 (61.6)                   
  Myocardial infarction, %                                                                                0.79
  Yes                                                      47 (3.0)         235 (3.2)                     
  No                                                       1499 (97.0)      7178 (96.8)                   
  Congestive heart failure, %                                                                             0.12
  Yes                                                      516 (33.4)       2324 (31.4)                   
  No                                                       1030 (66.6)      5089 (68.7)                   
  COPD, %                                                                                                 0.15
  Yes                                                      382 (24.7)       1706 (23.0)                   
  No                                                       1164 (75.3)      5707 (77.0)                   
  Diabetes, %                                                                                             0.06
  Yes                                                      468 (30.3)       2510 (33.9)                   
  No                                                       1078 (69.7)      4903 (66.1)                   
  Malignancy, %                                                                                           
  Yes                                                      59 (3.82)        154 (2.94)                    0.08
  No                                                       1487 (96.2)      5080 (97.1)                   

Standard errors or percentages are shown in parentheses.

COPD, chronic obstructive pulmonary disease; NA, not applicable; ONS, oral nutritional supplement; QIP, quality improvement program.

Average (standard deviation).

John Wiley & Sons, Ltd.

Hospitalization Rates {#jpen1606-sec-0200}
---------------------

Unadjusted hospitalization rates for 30 days, 60 days, and 90 days after enrollment to HHA (Table [2](#jpen1606-tbl-0002){ref-type="table"}) were compared with historic controls and concurrent controls, as were PSM cohorts for both historic and concurrent groups (Table [3](#jpen1606-tbl-0003){ref-type="table"}). Compared with the historic controls, the absolute reduction in 30‐day hospitalization post‐QIP was 3.6% (14.8%--11.2%), with a significant RR reduction of 24.3% (*P* = 0.007). For 60 and 90 days, absolute reductions in hospitalizations were 5.1% (22.6%--17.5%) and 4.9% (27.2%--22.3%), with significant RR reductions of 22.6% (*P* \< 0.001) and 18.0% (*P* = 0.001), respectively. Compared with concurrent controls, the absolute reduction in 30‐day hospitalizations was 2.5% (13.7%--11.2%), with a significant RR reduction of 18.2% (*P* = 0.002). For 60 and 90 days post‐QIP, in comparison with the concurrent control group, there were absolute reductions in hospitalizations of 3.3% (20.8%--17.5%) and 3% (25.3%--22.3%), with significant RR reductions of 15.8% (*P* = 0.009) and 11.8% (*P* = 0.03), respectively. Statistically significant reductions in 30‐day, 60‐day, and 90‐day hospitalizations post‐QIP were observed for outpatients (all *P* \< 0.05) and SNF patients (all *P* \< 0.05). For hospital patients, hospitalization rates were lower, but reductions were not statistically significant (all *P* \> 0.05).

###### 

Hospitalization Rates at 30, 60, and 90 Days Postenrollment to Home Health, Compared by Recruitment Types

                                                       QIP (n = 1546)   Historic Control (n = 7413)   Concurrent Control (n = 5235)                 
  ---------------------------------------------------- ---------------- ----------------------------- ------------------------------- ------ ------ ------
  30 day[a](#jpen1606-tbl2-note-0001){ref-type="fn"}   173              11.2                          1096                            14.8   716    13.7
  60 day[a](#jpen1606-tbl2-note-0001){ref-type="fn"}   270              17.5                          1676                            22.6   1091   20.8
  90 day[a](#jpen1606-tbl2-note-0001){ref-type="fn"}   344              22.3                          2018                            27.2   1325   25.3
  Hospital                                                                                                                                          
  30 day                                               122              11.6                          626                             13.5   438    12.2
  60 day                                               192              18.3                          974                             20.9   690    19.2
  90 day                                               246              23.5                          1175                            25.3   837    23.3
  Skilled nursing facility                                                                                                                          
  30 day[a](#jpen1606-tbl2-note-0001){ref-type="fn"}   31               10.5                          353                             17.3   209    17.3
  60 day[a](#jpen1606-tbl2-note-0001){ref-type="fn"}   50               17.0                          508                             24.9   282    23.3
  90 day[a](#jpen1606-tbl2-note-0001){ref-type="fn"}   60               20.4                          599                             29.4   335    27.7
  Outpatient clinics                                                                                                                                
  30 day[a](#jpen1606-tbl2-note-0001){ref-type="fn"}   20               9.8                           117                             16.2   69     15.7
  60 day[a](#jpen1606-tbl2-note-0001){ref-type="fn"}   28               13.8                          194                             26.9   119    27.0
  90 day[a](#jpen1606-tbl2-note-0001){ref-type="fn"}   38               18.7                          244                             33.8   153    34.7

QIP, quality improvement program.

*P* \< 0.05 when comparing QIP with historic control and QIP with concurrent control.

John Wiley & Sons, Ltd.

###### 

RR Reduction Using Historic and Concurrent Control Groups as Comparators

  Comparison Group: Historic Controls                                                                                                      
  ------------------------------------- ------ ------------------- ------- ------ ------------------- --------- ------ ------------------- --------
  Overall                                                                                                                                  
  Unadjusted                            1269    0.76 (0.65--0.88)  0.007   1946    0.77 (0.69--0.87)  \<0.001   2362    0.82 (0.74--0.90)  0.001
  PS matched                            383     0.81 (0.65--0.88)  0.04    604     0.80 (0.68--0.94)  0.006     750     0.84 (0.73--0.97)  0.02
  Hospital                                                                                                                                 
  Unadjusted                            748     0.86 (0.71--1.05)  0.14    1166    0.87 (0.75--1.02)  0.09      1421    0.93 (0.81--1.07)  0.29
  PS matched                            266     0.88 (0.70--1.13)  0.32    428     0.85 (0.70--1.03)  0.09      531     0.90 (0.76--1.07)  0.23
  SNF                                                                                                                                      
  Unadjusted                            384     0.61 (0.42--0.88)  0.008   558     0.68 (0.51--0.91)  0.01      659     0.69 (0.53--0.91)  0.007
  PS matched                            77      0.63 (0.40--0.99)  0.05    115     0.73 (0.50--1.06)  0.09      138     0.73 (0.52--1.03)  0.07
  Outpatient clinic                                                                                                                        
  Unadjusted                            137     0.61 (0.38--0.98)  0.04    222     0.51 (0.35--0.76)  0.001     282     0.55 (0.39--0.78)  0.0007
  PS matched                            40      0.71 (0.38--1.33)  0.29    61      0.63 (0.38--1.04)  0.07      81      0.66 (0.43--1.03)  0.07

  Comparison Group: Concurrent Controls                                                                                                   
  --------------------------------------- ----- ------------------- ------- ------ ------------------- ------- ------ ------------------- --------
  Overall                                                                                                                                 
  Unadjusted                              889    0.82 (0.69--0.97)  0.002   1361    0.84 (0.73--0.96)  0.009   1669    0.88 (0.78--0.99)  0.03
  PS matched                              386    0.81 (0.66--0.99)  0.04    587     0.85 (0.72--0.99)  0.04    733     0.88 (0.76--1.02)  0.08
  Hospital                                                                                                                                
  Unadjusted                              560    0.95 (0.78--1.16)  0.63    882     0.95 (0.81--1.12)  0.54    1083    1.01 (0.87--1.16)  0.95
  PS matched                              251    0.96 (0.75--1.22)  0.82    379     1.03 (0.84--1.26)  0.79    473     1.09 (0.91--1.30)  0.37
  SNF                                                                                                                                     
  Unadjusted                              240    0.61 (0.42--0.89)  0.01    332     0.73 (0.54--0.98)  0.04    395     0.74 (0.56--0.97)  0.03
  PS matched                              85     0.53 (0.34--0.83)  0.005   126     0.61 (0.43--0.87)  0.007   153     0.60 (0.43--0.83)  0.002
  Outpatient clinic                                                                                                                       
  Unadjusted                              89     0.63 (0.38--1.04)  0.07    147     0.51 (0.34--0.77)  0.001   191     0.54 (0.38--0.77)  0.0007
  PS matched                              50     0.71 (0.40--1.24)  0.23    82      0.55 (0.35--0.87)  0.01    107     0.58 (0.39--0.87)  0.007

CI, confidence interval; N, number; PS, propensity score; QIP, quality improvement program; RR, relative risk; SNF, skilled nursing facility.

John Wiley & Sons, Ltd.

PSM results generated by Poisson regression models were consistent with the unadjusted comparative results, showing significant improvements in hospitalization rates during the 90‐day period for the overall patient population and significant improvements in outpatients and SNF patients (Table [3](#jpen1606-tbl-0003){ref-type="table"}).

Healthcare Resource Utilization {#jpen1606-sec-0210}
-------------------------------

During the 90‐day follow‐up period, significant reductions in healthcare resource utilization were observed for the overall QIP patient population (RR = 0.92, 95% CI 0.90--0.94, *P* \< 0.0001) and the subgroups (*P* values \< 0.001). Significant reductions for hospitalizations and outpatient visits were observed for the overall QIP patient population compared with historic controls; RRs were 0.81 (95% CI 0.74--0.90, *P* \< 0.001) and 0.83 (95% CI 0.81--0.85, *P* \< 0.0001), respectively. ED visits, however, were higher in the QIP group (RR = 1.46, 95% CI 1.27--1.69, *P* \< 0.0001). Similar results were observed for the 3 subgroups: admitted from hospital, outpatient clinics, and SNF (Table [4](#jpen1606-tbl-0004){ref-type="table"}). Sensitivity analysis showed that the results were consistent among all comparative analyses, with significant improvements for overall QIP patients.

###### 

Healthcare Resource Utilization During 90‐Day Period Using Historic Controls as Comparison

                      Overall                 
  ------------------- --------- ------ ------ ----------
  Inpatient visits    0.81      0.74   0.90   \<0.0001
  ED visits           1.46      1.27   1.69   \<0.0001
  Outpatient visits   0.83      0.81   0.85   \<0.0001
  Overall             0.92      0.90   0.94   \<.0001

                      Hospital                 
  ------------------- ---------- ------ ------ ----------
  Inpatient visits    0.89       0.79   0.99   0.0495
  ED visits           1.57       1.32   1.86   \<0.001
  Outpatient visits   0.82       0.79   0.84   \<0.0001
  Overall             0.92       0.90   0.95   \<.0001

                      Outpatient Clinic                 
  ------------------- ------------------- ------ ------ ----------
  Inpatient visits    0.57                0.43   0.76   0.0002
  ED visits           1.07                0.70   1.62   0.73
  Outpatient visits   0.73                0.67   0.79   \<0.0001
  Overall             0.87                0.81   0.92   \<.0001

                      Skilled Nursing Facility                 
  ------------------- -------------------------- ------ ------ --------
  Inpatient visits    0.74                       0.60   0.92   0.0075
  ED visits           1.19                       0.82   1.74   0.34
  Outpatient visits   0.91                       0.87   0.97   0.0023
  Overall             0.96                       0.91   0.99   0.0002

ED, emergency department; LCL, lower confidence limit; RR, relative risk; UCL, upper confidence limit.

John Wiley & Sons, Ltd.

Cost Savings {#jpen1606-sec-0220}
------------

Total savings from reduced healthcare resource utilization (ie, avoided hospitalizations, outpatient visits) during the 90‐day period was \$2,318,894; net savings per treated patient was \$1500 (Table [5](#jpen1606-tbl-0005){ref-type="table"}). The results of the sensitivity analysis coincided with the original findings; cost savings ranged between \$2,090,821 and \$2,809,845, and net savings per treated patient ranged between \$1366 and \$1843.

###### 

Cost Savings During 90‐Day Period Using Historical Controls as Comparison

  QIP                                                                      USD Amount
  ---------------------------------------------------------------------- --------------
  Total HCRU costs[a](#jpen1606-tbl5-note-0002){ref-type="fn"}            \$13,065,954
  Total QIP resource costs[b](#jpen1606-tbl5-note-0003){ref-type="fn"}     \$402,794
  Per‐patient QIP resource cost                                              \$261
  QIP total cost per patient                                                 \$8712

  Historical Controls               USD Amount
  ------------------------------- --------------
  Total HCRU costs                 \$75,701,028
  Total QIP resource costs             \$0
  Per‐patient QIP resource cost        \$0
  Comparison per‐patient cost        \$10,212

  Cost Savings                                     USD Amount
  ----------------------------------------------- -------------
  For overall QIP patient population (n = 1546)    \$2,318,894
  Per patient                                        \$1500

HCRU, healthcare resource utilization; ONS, oral nutritional supplement; QIP, quality improvement program; USD, U.S. dollar.

Costs incurred from hospitalizations and emergency department and outpatient visits.

Costs of QIP implementation include patient screening and assessment (n = 5688) as well as education, follow‐ups, ONS bottles, and delivery (n = 1546).

John Wiley & Sons, Ltd.

Phone Survey Results {#jpen1606-sec-0230}
--------------------

Of the 1546 QIP patients, 813 responded to the follow‐up telephone survey (52.6%), and 764 (94.0%) patients reported consuming ONS while receiving home healthcare. During the first 30 days of the QIP period, participants reported consuming an average of 1.12 bottles/d of standard ONS (Ensure, n = 507), 1.09 bottles/d of diabetes‐specific ONS (Glucerna, n = 266), and 1.13 bottles/d of renal‐specific ONS (Nepro, n = 40) (Appendix Table [A1](#jpen1606-tbl-0006){ref-type="table"}). Participants reported that the importance of nutrition care was almost always discussed with the HHA clinician during the home healthcare episode. Nutrition education was always discussed with 57.2% of participants, usually discussed with 27.7%, and sometimes discussed with 8.2%; the remaining 6.9% of patients were not sure or did not remember such discussions. Regarding continued ONS use if prescribed, nearly 60% were very likely to consume ONS beyond their home healthcare episode, and only 5.0% were unlikely to do so. The main factors influencing an "unlikely" response were affordability, taste, and swallowing difficulties.

Discussion {#jpen1606-sec-0240}
==========

Nutrition care is vital to achieving best outcomes for patients across the continuum of care, for which ONS is a highly effective treatment of malnutrition.[24](#jpen1606-bib-0024){ref-type="ref"} This study in the home healthcare setting employed a nutrition‐focused QIP to enhance comprehensive nutrition care for patients who were at risk or malnourished. With this QIP in place, RR of hospitalization was reduced by over 20% at 30 days, and the effect was largely sustained at 60 and 90 days. Reduction was observed consistently, regardless of whether historic or concurrent patient populations were used, and with or without adjustment of the comparator group by propensity matching of patients for sociodemographic variables and disease status. The reduced risk for hospitalization and outpatient visits among QIP HHA patients was associated with lower overall 90‐day healthcare resource utilization, which generated significant costs savings of \$2,318,894 for the entire QIP cohort or net savings of \$1500 per patient treated. The current AHC results on nutrition‐focused QIP in home healthcare are consistent with findings from the AHC in‐hospital, ONS nutrition‐focused QIP; the study led to total costs savings of \$4,896,758 or \$3858 per patient treated because of a shorter hospital length of stay and reductions in 30‐day unplanned readmissions.[19](#jpen1606-bib-0019){ref-type="ref"}

Although this AHC QIP led to reduced hospitalizations and outpatient visits, ED visits increased. Clearly, there remains room for further improvement and cost savings. A recent systematic review found that a large proportion of all ED visits in the United States were for nonurgent conditions.[25](#jpen1606-bib-0025){ref-type="ref"} Studies have also shown that ED rates can be lowered by educating patients on getting treatment in outpatient clinics for nonurgent conditions.[25](#jpen1606-bib-0025){ref-type="ref"}, [26](#jpen1606-bib-0026){ref-type="ref"}, [27](#jpen1606-bib-0027){ref-type="ref"} Future research is needed to further explore the impact of a nutrition‐based QIP on ED visits, as the reasons for ED visits in this population vary and may often be multifactorial.

This study included a large sample size, followed QIP methodology to implement changes systematically, and included a patient education component emphasizing nutrition awareness and compliance with ONS intake. In terms of limitations, our study used an observational real‐world QIP methodology rather than a randomized design. Although ONS compliance data were available through self‐reports for the majority of the QIP patients (52.6%), we did not fully capture such data for all participating patients. We also relied on administrative AHC data to confirm healthcare resource utilization rather than using a full claims data approach, so it did not account for healthcare visits outside of the AHC system. Because to date, ours is the first‐ever study to evaluate the costs and benefits of using ONS as part of a nutrition QIP in HHA, it is important to question whether the findings are generalizable. Although our findings represent 1 system\'s experience, we showcase the AHC system as uniquely suited to conduct such a study, since it delivers integrated care for inpatients and outpatients with a wide range of illness acuity and serves a population that is diverse by age, race, and socioeconomic status.

Importantly, nutrition interventions have been repeatedly shown to reduce unplanned readmissions.[28](#jpen1606-bib-0028){ref-type="ref"} It has been estimated that anywhere from 5% to 79% of readmissions may be preventable;[29](#jpen1606-bib-0029){ref-type="ref"} reduction of avoidable readmissions by 10% could lead to a national savings of \$1 billion or more.[30](#jpen1606-bib-0030){ref-type="ref"} The current findings support and extend prior reports on the benefit of ONS for patients at risk of malnutrition in terms of both clinical[31](#jpen1606-bib-0031){ref-type="ref"} and economic outcomes.[24](#jpen1606-bib-0024){ref-type="ref"}, [32](#jpen1606-bib-0032){ref-type="ref"} ONS use among such patients has been shown to reduce unplanned hospital readmissions,[31](#jpen1606-bib-0031){ref-type="ref"}, [33](#jpen1606-bib-0033){ref-type="ref"}, [34](#jpen1606-bib-0034){ref-type="ref"}, [35](#jpen1606-bib-0035){ref-type="ref"} and ONS use in the community improved clinically relevant outcomes and was cost‐effective.[32](#jpen1606-bib-0032){ref-type="ref"}

U.S. healthcare programs increasingly support integrated acute and postacute care. In 2010, the Hospital Readmission Reduction Program, as part of the Affordable Care Act, authorized the Centers for Medicare and Medicaid Services (CMS) to hold hospitals accountable for postdischarge patient care.[36](#jpen1606-bib-0036){ref-type="ref"}, [37](#jpen1606-bib-0037){ref-type="ref"} Under the Hospital Value‐Based Purchasing Program, CMS penalizes low‐performing hospitals for care that occurs up to 30 days postdischarge[38](#jpen1606-bib-0038){ref-type="ref"} by reducing their Medicare reimbursements.[39](#jpen1606-bib-0039){ref-type="ref"} New proposals for the Home Health Value‐Based Purchasing Model and Quality Reporting Program will likewise impact CMS reimbursement based on 30‐day readmission and other quality measures,[40](#jpen1606-bib-0040){ref-type="ref"} thus highlighting the importance of implementing similar nutrition QIPs to inform 30‐day readmission reductions for home health patients. Although 30‐day outcomes are informative, our HHA study used 90‐day hospital readmission as a primary outcome, since HHAs commonly care for people with chronic diseases---eg, COPD, CHF, and diabetes.[41](#jpen1606-bib-0041){ref-type="ref"} Also, as of 2018, CMS is expected to begin evaluating HHA care quality based on hospitalizations up to 90 days postenrollment.[42](#jpen1606-bib-0042){ref-type="ref"} Our real‐world study results show that nutrition care can play an important role in promoting health and economic benefits for HHA patients at malnutrition risk and for healthcare systems offering postacute care.

Conclusions {#jpen1606-sec-0250}
===========

Malnutrition is both a cause and consequence of poor health in adults; identification and treatment of malnutrition can help avert disease complications or relapses and can boost recovery. Given its ease of implementation and relatively low cost, nutrition is an appealing strategy for HHAs and other postacute care institutions. This study shows that at‐home use of ONS, as part of nutrition‐focused care, can reduce 30‐day, 60‐day, and 90‐day hospitalization rates and healthcare resource utilization, thus yielding improved health outcomes and significant cost savings.
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###### 

Results of a Phone Survey Conducted 30--45 Days Post--HHA Enrollment

  Survey Question                                                                                                                      Response             N (%)
  ----------------------------------------------------------------------------------------------------------------------------- ---------------------- ----------------
  During your home health episode, did you consume ONS?                                                                                  Yes              764 (94.0)
                                                                                                                                          No               49 (6.0)
  During your home health episode, how many bottles of ONS did you consume per day?                                                      1.12            507 (Ensure)
                                                                                                                                         1.09           266 (Glucerna)
                                                                                                                                         1.13             40 (Nepro)
  During your home health episode, how often did a home health team member discuss the importance of nutrition care with you?           Always            465 (57.2)
                                                                                                                                       Usually            225 (27.7)
                                                                                                                                      Sometimes            67 (8.2)
                                                                                                                                       Not sure            56 (6.9)
  If your doctor prescribed ONS beyond your home health episode, how likely would you be to consume ONS?                             Very likely          482 (59.3)
                                                                                                                                   Somewhat likely        247 (30.4)
                                                                                                                                  Somewhat unlikely        43 (5.3)
                                                                                                                                    Very unlikely          41 (5.0)
  If you would be unlikely to consume ONS, please select the primary reason:                                                      Affordability/cost          36
                                                                                                                                        Taste                 26
                                                                                                                                 Difficult swallowing         13
                                                                                                                                        Other                 9

HHA, home health agency; N, number; ONS, oral nutritional supplement.
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